Prevalence of recurrent pathogenic microdeletions and microduplications in over 9500 pregnancies

Prenatal Diagnosis

Volumn 35, Issue 8, 2015, Pages 801-809

  Grati, Francesca Romana ^a   Molina Gomes, Denise ^b   Ferreira, Jose Carlos Pinto B ^c   Dupont, Celine ^d   Alesi, Viola ^e   Gouas, Laetitia ^f   Horelli Kuitunen, Nina ^g   Choy, Kwong Wai ^h   García Herrero, Sandra ⁱ   de la Vega, Alberto Gonzalez ^j   Piotrowski, Krzysztof ^k   Genesio, Rita ^l   Queipo, Gloria ^m   Malvestiti, Barbara ^a   Hervé, Bérénice ^b,n   Benzacken, Brigitte ^d   Novelli, Antonio ^e   Vago, Philippe ^f   Piippo, Kirsi ^g   Leung, Tak Yeung ^h   Maggi, Federico ^a   Quibel, Thibault ^b   Tabet, Anne Claude ^d   Simoni, Giuseppe ^a   Vialard, François ^b,n   more..

^a Cytogenetics and Molecular Biology   (Italy)

^b CENTRE HOSPITALIER INTERCOMMUNAL   (France)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

^d HÔPITAL ROBERT DEBRÉ   (France)

^e BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^f UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^g Medix Laboratoriot Oy   (Finland)

^h CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

ⁱ IGenomix   (Spain)

^j Eurofins Megalab   (Spain)

^k POMERANIAN MEDICAL UNIVERSITY   (Poland)

^l UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^m HOSPITAL GENERAL DE MÉXICO   (Mexico)

ⁿ LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 21; CHROMOSOME DELETION; CHROMOSOME DUPLICATION; DESCRIPTIVE RESEARCH; DIAGNOSTIC VALUE; DIGEORGE SYNDROME; ECHOGRAPHY; FEMALE; FETUS DEATH; FETUS HEART; HOLOPROSENCEPHALY; HUMAN; KARYOTYPE; KARYOTYPING; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MICRODELETION; MICRODUPLICATION; MOSAICISM; PHENOTYPE; PREGNANCY DISORDER; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; ADULT; CHROMOSOME DISORDERS; EVALUATION STUDY; FOLLOW UP; GENETICS; INCIDENCE; PREGNANCY; PREVALENCE; PROCEDURES; SENSITIVITY AND SPECIFICITY;

ADULT; CHROMOSOME DELETION; CHROMOSOME DISORDERS; CHROMOSOME DUPLICATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KARYOTYPING; PREGNANCY; PRENATAL DIAGNOSIS; PREVALENCE; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84938570204     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4613     Document Type: Article

References (32)

1. Callaway JL, Shaffer LG, Chitty LS, et al. The clinical utility of microarray technologies applied to prenatal cytogenetics in the presence of a normal conventional karyotype: a review of the literature. Prenat Diagn 2013;33:1119-23.
2. Wapner RJ, Martin CL, Levy B, et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med 2012;367:2175-84.
3. Shaffer LG, Rosenfeld JA, Dabell MP, et al. Detection rates of clinically significant genomic alterations by microarray analysis for specific anomalies detected by ultrasound. Prenat Diagn 2012;32:986-95.
4. Lee CN, Lin SY, Lin CH, et al. Clinical utility of array comparative genomic hybridisation for prenatal diagnosis: a cohort study of 3171 pregnancies. BJOG 2012;119:614-25.
5. Armengol L, Nevado J, Serra-Juhe C, et al. Clinical utility of chromosomal microarray analysis in invasive prenatal diagnosis. Hum Genet 2012;131:513-23.
6. Park SJ, Jung EH, Ryu RS, et al. Clinical implementation of whole-genome array CGH as a first-tier test in 5080 pre and postnatal cases. Mol Cytogenet 2011;4:12.
7. Vialard F, Simoni G, Aboura A, et al. Prenatal BACs-on-Beads: a new technology for rapid detection of aneuploidies and microdeletions in prenatal diagnosis. Prenat Diagn 2011;31:500-8.
8. Vialard F, Simoni G, Gomes DM, et al. Prenatal BACs-on-Beads: the prospective experience of five prenatal diagnosis laboratories. Prenat Diagn 2012;32:329-35.
9. Gross SJ, Bajaj K, Garry D, et al. Rapid and novel prenatal molecular assay for detecting aneuploidies and microdeletion syndromes. Prenat Diagn 2011;31:259-66.
10. Grati FR, Vialard F, Gross S. BACs-on-Beads (BoBs) assay for the genetic evaluation of prenatal samples and products of conception. Methods Mol Biol 2015;1227:259-78.
11. Newcombe RG. Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med 1998;17:873-90.
12. Cooper GM, Coe BP, Girirajan S, et al. A copy number variation morbidity map of developmental delay. Nat Genet 2011;43:838-46.
13. American College of O, Gynecologists Committee on G. Committee Opinion No. 581: the use of chromosomal microarray analysis in prenatal diagnosis. Obstet Gynecol 2013;122:1374-7.
14. Botto LD, May K, Fernhoff PM, et al. A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 2003;112:101-7.
15. Goodship J, Cross I, LiLing J, et al. A population study of chromosome 22q11 deletions in infancy. Arch Dis Child 1998;79:348-51.
16. Devriendt K, Fryns JP, Mortier G, et al. The annual incidence of DiGeorge/velocardiofacial syndrome. J Med Genet 1998;35:789-90.
17. Oskarsdottir S, Vujic M, Fasth A. Incidence and prevalence of the 22q11 deletion syndrome: a population-based study in Western Sweden. Arch Dis Child 2004;89:148-51.
18. Ryan AK, Goodship JA, Wilson DI, et al. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet 1997;34:798-804.
19. Kobrynski LJ, Sullivan KE. Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet 2007;370:1443-52.
20. Besseau-Ayasse J, Violle-Poirsier C, Bazin A, et al. A French collaborative survey of 272 fetuses with 22q11.2 deletion: ultrasound findings, fetal autopsies and pregnancy outcomes. Prenat Diagn 2014;34:424-30.
21. Ou Z, Berg JS, Yonath H, et al. Microduplications of 22q11.2 are frequently inherited and are associated with variable phenotypes. Genet Med 2008;10:267-77.
22. Van Campenhout S, Devriendt K, Breckpot J, et al. Microduplication 22q11.2: a description of the clinical, developmental and behavioral characteristics during childhood. Genet Couns 2012;23:135-48.
23. Dupont C, Grati FR, Choy KW, et al. Prenatal diagnosis of 24 cases of microduplication 22q11.2: an investigation of phenotype-genotype correlations. Prenat Diagn 2014.
24. Shaikh TH, Kurahashi H, Saitta SC, et al. Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis. Hum Mol Genet 2000;9:489-501.
25. Marcato L, Turolla L, Pompilii E, et al. Prenatal phenotype of Williams-Beuren syndrome and of the reciprocal duplication syndrome. Clin Case Rep 2014;2:25-32.
26. Choy K, Kwok Y, Cheng Y, et al. Diagnostic accuracy of the BACs-on-Beads assay versus karyotyping for prenatal detection of chromosomal abnormalities: a retrospective consecutive case series. BJOG 2014.
27. Shaffer LG, Bui TH. Molecular cytogenetic and rapid aneuploidy detection methods in prenatal diagnosis. Am J Med Genet C Semin Med Genet 2007;145C:87-98.
28. Langlois S, Duncan A. Use of a DNA method, QF-PCR, in the prenatal diagnosis of fetal aneuploidies. J Obstet Gynaecol Can 2011;33:955-60.
29. Cheung EN, George SR, Andrade DM, et al. Neonatal hypocalcemia, neonatal seizures, and intellectual disability in 22q11.2 deletion syndrome. Genet Med 2014;16:40-4.
30. McDonald-McGinn DM, Emanuel BS, Zackai EH. 22q11.2 Deletion Syndrome, Pagon RA, Adam MP, Ardinger HH, et al. (eds). GeneReviews(R). Seattle (WA), 1993.
31. McDonald-McGinn DM, Tonnesen MK, Laufer-Cahana A, et al. Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: cast a wide FISHing net! Genet Med 2001;3:23-9.
32. Bassett AS, McDonald-McGinn DM, Devriendt K, et al. Practical guidelines for managing patients with 22q11.2 deletion syndrome. J Pediatr 2011;159:332-9.e1.